Cibc Private Wealth Group, LLC Tempest Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 133 shares of TPST stock, worth $129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133
Previous 133
-0.0%
Holding current value
$129
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TPST
# of Institutions
34Shares Held
2.4MCall Options Held
44.9KPut Options Held
109K-
Black Rock Inc. New York, NY550KShares$533,7330.0% of portfolio
-
Altium Capital Management LP New York, NY545KShares$528,6500.27% of portfolio
-
Geode Capital Management, LLC Boston, MA220KShares$213,4640.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$170,9070.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$125,6910.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $10.1M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...